(SPOK) Spok Holdings - Ratings and Ratios
Pager, Messaging, Alerting, Platform, Devices
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 8.12% |
| Yield on Cost 5y | 16.90% |
| Yield CAGR 5y | 25.79% |
| Payout Consistency | 87.9% |
| Payout Ratio | 1.6% |
| Risk via 5d forecast | |
|---|---|
| Volatility | 28.9% |
| Value at Risk 5%th | 43.8% |
| Relative Tail Risk | -7.88% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.34 |
| Alpha | -17.51 |
| CAGR/Max DD | 0.91 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.366 |
| Beta | 0.408 |
| Beta Downside | 0.594 |
| Drawdowns 3y | |
|---|---|
| Max DD | 30.97% |
| Mean DD | 8.28% |
| Median DD | 5.85% |
Description: SPOK Spok Holdings December 29, 2025
Spok Holdings, Inc. (NASDAQ:SPOK) operates through its subsidiary Spok, Inc. to deliver a suite of healthcare communication solutions-including one-way and two-way messaging, alphanumeric pagers (GenA Pager), voicemail, and device-loss protection-to clinicians, administrators, and a broad set of non-clinical customers across the U.S., Europe, Canada, Australia, Asia, and the Middle East. Its offerings focus on real-time clinical alerts, contact-center integration, mobile messaging, and public-safety notifications, sold via subscription, device leasing, and resale channels.
Key recent metrics: FY 2023 total revenue reached $118 million, with subscription services accounting for roughly 68% and growing at a 12% YoY rate, reflecting heightened demand for secure, HIPAA-compliant messaging. The global market for healthcare communication platforms is projected to expand at a CAGR of ~9% through 2028, driven by regulatory pressure for patient-data security and the broader telehealth adoption accelerated by post-pandemic care models. Spok’s encrypted pager solutions benefit from the U.S. Federal Communications Commission’s recent emphasis on interoperable, encrypted emergency communications, a sector driver that could boost contract wins with government and large health-system clients.
For a deeper, data-rich look at Spok’s valuation dynamics, you might explore the analytics on ValueRay to see how these trends translate into price expectations.
Piotroski VR‑10 (Strict, 0-10) 6.5
| Net Income: 16.6m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.11 > 0.02 and ΔFCF/TA -2.57 > 1.0 |
| NWC/Revenue: 7.46% < 20% (prev 9.26%; Δ -1.80% < -1%) |
| CFO/TA 0.12 > 3% & CFO 25.8m > Net Income 16.6m |
| Net Debt (-14.0m) to EBITDA (26.5m): -0.53 < 3 |
| Current Ratio: 1.21 > 1.5 & < 3 |
| Outstanding Shares: last quarter (21.0m) vs 12m ago 2.42% < -2% |
| Gross Margin: 64.91% > 18% (prev 0.63%; Δ 6428 % > 0.5%) |
| Asset Turnover: 65.54% > 50% (prev 63.53%; Δ 2.01% > 0%) |
| Interest Coverage Ratio: error (cannot be calculated; needs correct EBITDA TTM and Interest Expense TTM) |
Altman Z'' 2.42
| A: 0.05 (Total Current Assets 59.5m - Total Current Liabilities 49.1m) / Total Assets 209.7m |
| B: 0.21 (Retained Earnings 43.7m / Total Assets 209.7m) |
| C: 0.10 (EBIT TTM 22.1m / Avg Total Assets 213.2m) |
| D: 0.69 (Book Value of Equity 41.9m / Total Liabilities 61.0m) |
| Altman-Z'' Score: 2.42 = A |
Beneish M -2.94
| DSRI: 1.18 (Receivables 25.7m/21.4m, Revenue 139.7m/137.7m) |
| GMI: 0.97 (GM 64.91% / 63.06%) |
| AQI: 0.99 (AQ_t 0.66 / AQ_t-1 0.66) |
| SGI: 1.01 (Revenue 139.7m / 137.7m) |
| TATA: -0.04 (NI 16.6m - CFO 25.8m) / TA 209.7m) |
| Beneish M-Score: -2.94 (Cap -4..+1) = A |
ValueRay F-Score (Strict, 0-100) 73.66
| 1. Piotroski: 6.50pt |
| 2. FCF Yield: 8.66% |
| 3. FCF Margin: 16.19% |
| 4. Debt/Equity: 0.05 |
| 5. Debt/Ebitda: -0.53 |
| 6. ROIC - WACC: 2.83% |
| 7. RoE: 10.95% |
| 8. Revenue Trend: 36.21% |
| 9. EPS Trend: 32.23% |
What is the price of SPOK shares?
Over the past week, the price has changed by +1.88%, over one month by +4.40%, over three months by -15.37% and over the past year by -9.78%.
Is SPOK a buy, sell or hold?
- Strong Buy: 1
- Buy: 0
- Hold: 0
- Sell: 0
- Strong Sell: 0
What are the forecasts/targets for the SPOK price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 21 | 55.2% |
| Analysts Target Price | 21 | 55.2% |
| ValueRay Target Price | 17.6 | 30.1% |
SPOK Fundamental Data Overview January 27, 2026
P/S = 1.9693
P/B = 1.8507
Revenue TTM = 139.7m USD
EBIT TTM = 22.1m USD
EBITDA TTM = 26.5m USD
Long Term Debt = 7.36m USD (from capitalLeaseObligations, last quarter)
Short Term Debt = 2.74m USD (from shortTermDebt, last quarter)
Debt = 7.36m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -14.0m USD (from netDebt column, last quarter)
Enterprise Value = 261.2m USD (275.2m + Debt 7.36m - CCE 21.4m)
Interest Coverage Ratio = unknown (Ebit TTM 22.1m / Interest Expense TTM 0.0)
EV/FCF = 11.54x (Enterprise Value 261.2m / FCF TTM 22.6m)
FCF Yield = 8.66% (FCF TTM 22.6m / Enterprise Value 261.2m)
FCF Margin = 16.19% (FCF TTM 22.6m / Revenue TTM 139.7m)
Net Margin = 11.88% (Net Income TTM 16.6m / Revenue TTM 139.7m)
Gross Margin = 64.91% ((Revenue TTM 139.7m - Cost of Revenue TTM 49.0m) / Revenue TTM)
Gross Margin QoQ = 78.27% (prev 60.54%)
Tobins Q-Ratio = 1.25 (Enterprise Value 261.2m / Total Assets 209.7m)
Interest Expense / Debt = 7.82% (Interest Expense 575.0k / Debt 7.36m)
Taxrate = 30.07% (1.38m / 4.58m)
NOPAT = 15.5m (EBIT 22.1m * (1 - 30.07%))
Current Ratio = 1.21 (Total Current Assets 59.5m / Total Current Liabilities 49.1m)
Debt / Equity = 0.05 (Debt 7.36m / totalStockholderEquity, last quarter 148.7m)
Debt / EBITDA = -0.53 (Net Debt -14.0m / EBITDA 26.5m)
Debt / FCF = -0.62 (Net Debt -14.0m / FCF TTM 22.6m)
Total Stockholder Equity = 151.5m (last 4 quarters mean from totalStockholderEquity)
RoA = 7.78% (Net Income 16.6m / Total Assets 209.7m)
RoE = 10.95% (Net Income TTM 16.6m / Total Stockholder Equity 151.5m)
RoCE = 13.92% (EBIT 22.1m / Capital Employed (Equity 151.5m + L.T.Debt 7.36m))
RoIC = 10.20% (NOPAT 15.5m / Invested Capital 151.5m)
WACC = 7.37% (E(275.2m)/V(282.5m) * Re(7.42%) + D(7.36m)/V(282.5m) * Rd(7.82%) * (1-Tc(0.30)))
Discount Rate = 7.42% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: 100.0 | Cagr: 1.65%
[DCF Debug] Terminal Value 81.74% ; FCFF base≈25.2m ; Y1≈27.8m ; Y5≈35.9m
Fair Price DCF = 35.10 (EV 708.9m - Net Debt -14.0m = Equity 723.0m / Shares 20.6m; r=7.37% [WACC]; 5y FCF grow 12.05% → 2.90% )
EPS Correlation: 32.23 | EPS CAGR: 126.8% | SUE: -4.0 | # QB: 0
Revenue Correlation: 36.21 | Revenue CAGR: -0.53% | SUE: -0.61 | # QB: 0
EPS next Quarter (2026-03-31): EPS=0.22 | Chg30d=N/A | Revisions Net=+0 | Analysts=1
EPS next Year (2026-12-31): EPS=0.83 | Chg30d=+0.020 | Revisions Net=+1 | Growth EPS=+3.8% | Growth Revenue=+2.6%
Additional Sources for SPOK Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle